
Sequencing solutions for global health and sustainability
Core product: Low-pass whole genome sequencing (LPWGS) plus cloud-based imputation and analytics (SaaS)
Markets: Human, plant, and animal genomics (research, clinical, agrigenomics)
Founded from: Spin-out of the New York Genome Center
Total funding: $16.2M (reported)
Latest round: Series A, $10M (Oct 26, 2021)
Reducing cost and increasing scalability of whole-genome data generation and interpretation for research, clinical, and agricultural use cases.
Genomics / Biotechnology
$3,000,000
$10,000,000
“Includes strategic investors with agrifood and life-science focus (e.g., Lewis & Clark AgriFood, Spero Ventures) and participation from VC firms across rounds”